BCYC — Bicycle Therapeutics Share News
0.000.00%
Last trade - 00:00- $286.23m
- -$272.44m
- $72.59m
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
U.S. STOCKS ON THE MOVE-Ford Motor, Cleveland-Cliffs, Exelon Corp
Bicycle Therapeutics rises as cancer drug study shows positive response
Bicycle Therapeutics rises on 'fast track' tag for cancer therapy
Brief: Bicycle Therapeutics Announces FDA Fast Track Designation For Bt8009
Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary
Brief: Bicycle Therapeutics Reports Third Quarter 2022 Financial Results
Bicycle Therapeutics PLC expected to post a loss of 89 cents a share - Earnings Preview
Brief: Bicycle Therapeutics Announces Publication Of Article Highlighting Preclinical Data From BT8009 Program
Brief: Bicycle Therapeutics Announces Bt5528 Phase I Dose Escalation Results In Patients With Advanced Solid Tumors
U.S. STOCKS ON THE MOVE-Pfizer, Nvidia, Boeing, SAIC, BioAffinity, Polestar
U.S. STOCKS ON THE MOVE-Kroger, J.Jill, Twin Disc, Abbvie
U.S. STOCKS ON THE MOVE-Arcturus, Five Below, Mullen
U.S. STOCKS ON THE MOVE-Nvidia, Nutanix, Comera, chip stocks
Cowen starts Bicycle Therapeutics with 'outperform' rating
Brief: Bicycle Therapeutics Says Qtrly Net Loss Was $26.8 Million
Brief: Bicycle Therapeutics, Some Units Enter Into Second Amendment To Co's Loan And Security Agreement With Hercules Capital
Brief: Bicycle Therapeutics Reports Publication Of BT7480 Preclinical Data In The Journal Of Medicinal Chemistry
Brief: Bicycle Therapeutics To Present Trials In Progress Poster Featuring Bt7480 Phase I/Ii Clinical Trial At The 2022 Asco Annual Meeting